75 related articles for article (PubMed ID: 729968)
1. Antitumor activity of 2,6-bis(halomethyl)piperidines on rat ascites hepatomas.
Miyamoto K; Sanae F; Koshiura R
Gan; 1978 Oct; 69(5):703-7. PubMed ID: 729968
[No Abstract] [Full Text] [Related]
2. Combination antitumor effect with central nervous system depressants on rat ascites hepatomas.
Koshiura R; Miyamoto K; Sanae F
Gan; 1980 Feb; 71(1):45-51. PubMed ID: 7380136
[TBL] [Abstract][Full Text] [Related]
3. New antitumor amino acid derivative, A-748, evaluated in rat ascites hepatomas.
Fujita H; Sakurai T; Toyoshima S
Cancer Treat Rep; 1979 Feb; 63(2):223-4. PubMed ID: 445498
[No Abstract] [Full Text] [Related]
4. [Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Satoh H; Taguchi H; Yahagi S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):287-91. PubMed ID: 2137321
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor activity of 2,6-bis(halomethyl)piperidines on Ehrlich ascites carcinoma (author's transl)].
Miyamoto K; Sanae F; Koshiura R; Tsuchiya T; Sawanishi H
Yakugaku Zasshi; 1977 Oct; 97(10):1150-4. PubMed ID: 592110
[No Abstract] [Full Text] [Related]
6. The antitumor effect of a novel nitrosourea, tauromustine, at intravenous administration in rat. Cure of hepatomas.
Roos G; el Hag IA; Christensson PI; Stenram U
Anticancer Res; 1991; 11(5):1763-6. PubMed ID: 1837442
[TBL] [Abstract][Full Text] [Related]
7. Rat hepatomas: chemotherapy with lycurim and pyrazofurin.
Lui MS; Jackson RC; Harkrader RJ; Weber G
J Natl Cancer Inst; 1982 Apr; 68(4):665-8. PubMed ID: 6951080
[TBL] [Abstract][Full Text] [Related]
8. mRNA levels and enzyme activities of protein phosphatases in drug-resistant rat ascites hepatomas.
Saadat M; Saeki H; Kudo T; Mizuno Y; Kikuchi K
Oncol Res; 1995; 7(10-11):505-10. PubMed ID: 8866662
[TBL] [Abstract][Full Text] [Related]
9. Improved antitumor efficacy and reduced toxicity of liposomes containing bufadienolides.
Hu K; Zhu L; Liang H; Hu F; Feng J
Arch Pharm Res; 2011 Sep; 34(9):1487-94. PubMed ID: 21975810
[TBL] [Abstract][Full Text] [Related]
10. Schedule dependency of anticancer effect of 1-beta-D-arabinofuranosylcytosine on rat ascites hepatomas.
Abe I; Sato S; Watanabe M; Sato H
Sci Rep Res Inst Tohoku Univ Med; 1978 Sep; 25(1-2):20-3. PubMed ID: 741221
[No Abstract] [Full Text] [Related]
11. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma].
Satoh H
Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between chemical reactions and antitumor activities of bis(haloalkyl)piperidine derivatives (author's transl)].
Miyamoto K; Sanae F; Koshiura R; Fukuda S
Yakugaku Zasshi; 1980 Nov; 100(11):1151-60. PubMed ID: 7205559
[No Abstract] [Full Text] [Related]
13. Antitumor effect of a new antibiotic, neothramycin.
Hisamatsu T; Uchida S; Takeuchi T; Ishizuka M; Umezawa H
Gan; 1980 Jun; 71(3):308-12. PubMed ID: 7418976
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic, clinico-pharmacologic and clinical effects of Libexin.
Harsányi K; Tardos L; Fehér I; Nagy G
Boll Chim Farm; 1973 Oct; 112(10):691-9. PubMed ID: 4782264
[No Abstract] [Full Text] [Related]
15. [Antitumor spectrum of 7-N-(p-hydroxyphenyl) mitomycin C (KW 2083) in rat ascites hepatoma].
Sato H; Taguchi H; Kobayashi Y
Gan No Rinsho; 1982; 28(2):122-4. PubMed ID: 6820669
[No Abstract] [Full Text] [Related]
16. Enhanced antitumor activity of mitomycin C conjugated with anti-alpha-fetoprotein antibody by a novel method of conjugation.
Kato Y; Tsukada Y; Hara T; Hirai H
J Appl Biochem; 1983; 5(4-5):313-9. PubMed ID: 6207159
[TBL] [Abstract][Full Text] [Related]
17. [Ornithine decarboxylase activity in malignant tumors].
Siatkin SP; Berezov TT
Vopr Med Khim; 1980; 26(1):121-4. PubMed ID: 7368616
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of conjugates of adriamycin with antibodies to alpha-fetoprotein and their properties].
Nishiwaki S; Takei N; Higashi T; Hibi N; Tsukada Y; Hirai H
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1591-7. PubMed ID: 6206799
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a new amino acid derivative, N6,N9-bis-(butyloxycarbonylaminomethyl)-L-citrulline.
Fujita H; Seto Y; Sakurai T; Ichimura H; Satoh H; Toyoshima S
Gan; 1978 Feb; 69(1):99-101. PubMed ID: 205478
[TBL] [Abstract][Full Text] [Related]
20. Suggestive evidence for relationship between sensitivity and repair capability in rat ascites hepatoma cells treated with the antitumor agent, 1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide.
Fukuda S; Koshiura R; Miyamoto K; Hatano M
Gan; 1977 Apr; 68(2):175-82. PubMed ID: 196969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
